AVTX Avalo Therapeutics Inc.: Multiplikator Forward P/S

Logo korporat perusahaan Avalo Therapeutics Inc (AVTX)

The forward price-to-sales valuation reflects the dynamics of Avalo Therapeutics, Inc (AVTX), a biotech startup developing treatments for rare immune pathologies. The value of 7035.20 reflects the metric's balance, confirming market expectations for new molecules. Stable supply to research centers is ensured through the diversification of logistics routes. However, geopolitical risks and patent disputes create barriers to the global scaling of pharmaceutical developments.

AVTX (avalotx.com) riwayat Rasio rega marang prakiraan pendapatan saka 04.07.2022 nganti 16.11.2026

avalotx.com (AVTX) - rincian metrik lan laporan keuangan

- rega saiki lan proyeksi nilai saham:
Analisis wiwitan perusahaan:Avalo Therapeutics Inc. (AVTX)
Produk asli Avalo Therapeutics, Inc

This metric is calculated as the ratio of the current market capitalization of Avalo Therapeutics, Inc (AVTX) to projected sales volume, measuring the extent to which market value is inflated relative to future cash flows. For the biotechnology sector specializing in exclusive treatments for rare pathologies, the forward price-to-sales ratio reflects market expectations regarding the company's monopoly status, where sharp spikes on the chart signal a risk that the asset is overbought.

Pesaing wigati

Multiplikator Forward P/S ARGX (argenx.com)|BioNTech Group (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ABIVAX - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|Protagonist (PTGX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Immunovant Inc|Rasio rega marang prakiraan pendapatan Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|Rasio rega marang prakiraan pendapatan CLDX (Celldex Therapeutics)|Rasio rega marang prakiraan pendapatan Aurinia Pharma AUPH|Rega forward marang dodolan BCRX|VERA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PGEN (Intrexon)|Multiplikator forward rega marang pendapatan PHAR (Pharming)|NKTR (Nektar) - Rega forward marang dodolan|Multiplikator Forward P/S UPB (upstreambio.com)|ZBIO (Zenas Biopharma Inc) - Rega mangsa ngarep marang pendapatan|IMNM - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Gossamer Bio Inc GOSS|KALV: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Septerna Pharma|PVLA (Pieris Corp) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan SVRA|Multiplikator Forward P/S RIGL|Multiplikator forward rega marang pendapatan AnaptysBio Corp ANAB|Astria Therapeutics Inc - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Multiplikator forward rega marang pendapatan|KYTX: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Tiziana Life Sciences|Cabaletta Bio, Inc (CABA) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan VTYX (Ventyx Biosciences)|Rasio kapitalisasi marang dodolan sing dikarepake theratech.com|Multiplikator Forward P/S ELDN (eledon.com)|AGEN - Multiplikator forward rega marang pendapatan|CLYM - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan ZURA|ATYR: Multiplikator Forward P/S|Adagene Corp (ADAG) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan IMA|Shattuck Labs, Inc. - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Equillium Inc (EQ)|Multiplikator Forward P/S Connect Biopharma Holdings (CNTB)|Rasio rega marang prakiraan pendapatan Immunic, Inc. IMUX|Multiplikator Forward P/S Atara Biotherapeutics ATRA|IFRX - Rasio rega marang prakiraan pendapatan|XFOR: Rasio rega marang prakiraan pendapatan|ACET: Multiplikator Forward P/S|CELU - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan inmunebio.com|Kapitalisasi marang prakiraan pendapatan BRNS (barinthusbio.com)|Multiplikator Forward P/S KZR|Multiplikator Forward P/S SAB Biotherapeutics, Inc (SABS)|Multiplikator Forward P/S AKTX (Akari Therapeutics, Plc)|Multiplikator Forward P/S enlivex.com ENLV|QTTB: Multiplikator forward rega marang pendapatan|GOVX - Multiplikator Forward P/S|Edesa Biotech Inc (EDSA) - Rasio rega marang prakiraan pendapatan|IBIO - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan carismatx.com|XTLB: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalisasi marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan aptevotherapeutics.com APVO|AIM - Multiplikator forward rega marang pendapatan|Aditxt - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake GRI Bio Corporation GRI|xortx.com (XRTX) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep reshapelifesciences.com (HIND)|Rasio rega marang prakiraan pendapatan Revelation Bio|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Indaptus Therapeutics, Inc. INDP|Rasio rega marang prakiraan pendapatan BiondVax Pharmaceuticals (SCNI)|Multiplikator forward rega marang pendapatan CalciMedica CALI|Rasio rega marang prakiraan pendapatan Affimed AFMD|ALLK - Multiplikator forward rega marang pendapatan|HOOKIPA Pharma, Inc. - Multiplikator Forward P/S|Rega forward marang dodolan IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Multiplikator forward rega marang pendapatan|Ocean Biomedical Corp (OCEA) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator Forward P/S thirdharmonicbio.com